TW202220666A - 含有賽佩普斯特(sepetaprost)之醫藥製劑 - Google Patents

含有賽佩普斯特(sepetaprost)之醫藥製劑 Download PDF

Info

Publication number
TW202220666A
TW202220666A TW110129745A TW110129745A TW202220666A TW 202220666 A TW202220666 A TW 202220666A TW 110129745 A TW110129745 A TW 110129745A TW 110129745 A TW110129745 A TW 110129745A TW 202220666 A TW202220666 A TW 202220666A
Authority
TW
Taiwan
Prior art keywords
glaucoma
ocular hypertension
treatment
mentioned
pharmaceutical preparation
Prior art date
Application number
TW110129745A
Other languages
English (en)
Chinese (zh)
Inventor
山元誉子
谷口孝純
島崎敦
木村恵利香
Original Assignee
日商參天製藥股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商參天製藥股份有限公司 filed Critical 日商參天製藥股份有限公司
Publication of TW202220666A publication Critical patent/TW202220666A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/558—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW110129745A 2020-08-13 2021-08-12 含有賽佩普斯特(sepetaprost)之醫藥製劑 TW202220666A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020136796 2020-08-13
JP2020-136796 2020-08-13

Publications (1)

Publication Number Publication Date
TW202220666A true TW202220666A (zh) 2022-06-01

Family

ID=80248014

Family Applications (1)

Application Number Title Priority Date Filing Date
TW110129745A TW202220666A (zh) 2020-08-13 2021-08-12 含有賽佩普斯特(sepetaprost)之醫藥製劑

Country Status (7)

Country Link
US (1) US20230285411A1 (cg-RX-API-DMAC7.html)
EP (1) EP4197540A4 (cg-RX-API-DMAC7.html)
JP (1) JPWO2022034909A1 (cg-RX-API-DMAC7.html)
KR (1) KR20230051199A (cg-RX-API-DMAC7.html)
CN (1) CN115768433A (cg-RX-API-DMAC7.html)
TW (1) TW202220666A (cg-RX-API-DMAC7.html)
WO (1) WO2022034909A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202404569A (zh) 2022-04-22 2024-02-01 日商參天製藥股份有限公司 含有賽佩普斯特(Sepetaprost)之眼科用組合物
TW202517277A (zh) * 2023-10-10 2025-05-01 日商參天製藥股份有限公司 含有賽佩普斯特(Sepetaprost)之點眼液

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011013651A (ja) 2009-07-03 2011-01-20 Mitsumasa Maeda フレキシブルディスプレイのれん
KR101768235B1 (ko) 2009-07-28 2017-08-14 오노 야꾸힝 고교 가부시키가이샤 이환식 화합물 및 이의 의약 용도
WO2019124489A1 (ja) * 2017-12-21 2019-06-27 参天製薬株式会社 セペタプロストとep2アゴニストとの組み合わせ医薬
EP3730138B1 (en) * 2017-12-21 2024-02-14 Santen Pharmaceutical Co., Ltd. Combination of sepetaprost and ripasudil for use in the prophylaxis or treatment of glaucoma or ocular hypertension
US11666563B2 (en) * 2017-12-28 2023-06-06 Santen Pharmaceutical Co., Ltd. Pharmaceutical preparation containing pyridyl aminoacetic acid compound
JP2022508715A (ja) * 2018-10-15 2022-01-19 オキュフィア・ファーマ・インコーポレイテッド 緑内障および関連状態の処置のための方法および組成物

Also Published As

Publication number Publication date
JPWO2022034909A1 (cg-RX-API-DMAC7.html) 2022-02-17
EP4197540A4 (en) 2024-06-19
KR20230051199A (ko) 2023-04-17
US20230285411A1 (en) 2023-09-14
WO2022034909A1 (ja) 2022-02-17
CN115768433A (zh) 2023-03-07
EP4197540A1 (en) 2023-06-21

Similar Documents

Publication Publication Date Title
JP6383058B2 (ja) スルホンアミド化合物の組み合わせ
EP2671586B1 (en) Drug therapy for preventing or treating glaucoma
US20220387372A1 (en) Medicament comprising combination of sepetaprost and rho-associated coiled-coil containing protein kinase inhibitor
US20140018350A1 (en) Combination of sulfonamide compound and tafluprost
JP7346305B2 (ja) ピリジルアミノ酢酸化合物を含有する医薬製剤
CN115768433A (zh) 含有司培前列素的医药制剂
JP2005047909A (ja) ピペリジン誘導体を有効成分とする掻痒治療剤
JPWO2005079792A1 (ja) 重症糖尿病網膜症の予防又は治療剤
HK40102807B (en) Combination of sepetaprost and netarsudil for use in the prophylaxis or treatment of glaucoma or ocular hypertension
HK40102807A (en) Combination of sepetaprost and netarsudil for use in the prophylaxis or treatment of glaucoma or ocular hypertension
JP2023110029A (ja) オミデネパグの組合せ
HUT65880A (en) Process for preparation of ophtalmological medicaments containing pyridine derivatives usefules for treatment of ocular hypertension
EA043474B1 (ru) Комбинация омиденепага
EA050493B1 (ru) ЛЕКАРСТВЕННОЕ СРЕДСТВО, СОДЕРЖАЩЕЕ КОМБИНАЦИЮ СЕПЕТАПРОСТА И ИНГИБИТОРА Rho-АССОЦИИРОВАННОЙ ПРОТЕИНКИНАЗЫ, СОДЕРЖАЩЕЙ СУПЕРСПИРАЛЬ
HK40029829B (en) Combination of sepetaprost and ripasudil for use in the prophylaxis or treatment of glaucoma or ocular hypertension
HK1236848B (en) Pharmacotherapy for preventing or treating glaucoma
HK40031074A (en) Pharmaceutical preparation containing pyridyl aminoacetic acid compound
US20040006142A1 (en) Ocular tension depressor